Literature DB >> 1322798

The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling.

E J Lowenstein1, R J Daly, A G Batzer, W Li, B Margolis, R Lammers, A Ullrich, E Y Skolnik, D Bar-Sagi, J Schlessinger.   

Abstract

A cDNA clone encoding a novel, widely expressed protein (called growth factor receptor-bound protein 2 or GRB2) containing one src homology 2 (SH2) domain and two SH3 domains was isolated. Immunoblotting experiments indicate that GRB2 associates with tyrosine-phosphorylated epidermal growth factor receptors (EGFRs) and platelet-derived growth factor receptors (PDGFRs) via its SH2 domain. Interestingly, GRB2 exhibits striking structural and functional homology to the C. elegans protein sem-5. It has been shown that sem-5 and two other genes called let-23 (EGFR like) and let-60 (ras like) lie along the same signal transduction pathway controlling C. elegans vulval induction. To examine whether GRB2 is also a component of ras signaling in mammalian cells, microinjection studies were performed. While injection of GRB2 or H-ras proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of GRB2 together with H-ras protein stimulated DNA synthesis. These results suggest that GRB2/sem-5 plays a crucial role in a highly conserved mechanism for growth factor control of ras signaling.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322798     DOI: 10.1016/0092-8674(92)90167-b

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  419 in total

1.  Regulation of Ras signaling specificity by protein kinase C.

Authors:  G Rusanescu; T Gotoh; X Tian; L A Feig
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Ligand-receptor binding measured by laser-scanning imaging.

Authors:  P Zuck; Z Lao; S Skwish; J F Glickman; K Yang; J Burbaum; J Inglese
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

3.  The endocytic protein intersectin is a major binding partner for the Ras exchange factor mSos1 in rat brain.

Authors:  X K Tong; N K Hussain; E de Heuvel; A Kurakin; E Abi-Jaoude; C C Quinn; M F Olson; R Marais; D Baranes; B K Kay; P S McPherson
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

Review 4.  Recent developments in lymphocyte activation: linking kinases to downstream signaling events.

Authors:  J L Clements; G A Koretzky
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 5.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

6.  Fluorescence intensity multiple distributions analysis: concurrent determination of diffusion times and molecular brightness.

Authors:  K Palo; U Mets; S Jäger; P Kask; K Gall
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

7.  Ajuba, a novel LIM protein, interacts with Grb2, augments mitogen-activated protein kinase activity in fibroblasts, and promotes meiotic maturation of Xenopus oocytes in a Grb2- and Ras-dependent manner.

Authors:  R K Goyal; P Lin; J Kanungo; A S Payne; A J Muslin; G D Longmore
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

8.  Ligand-induced changes in dynamics in the RT loop of the C-terminal SH3 domain of Sem-5 indicate cooperative conformational coupling.

Authors:  Josephine C Ferreon; Vincent J Hilser
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

9.  Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen.

Authors:  S D Liberles; S T Diver; D J Austin; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

10.  The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer.

Authors:  Leo Y Luo; Eejung Kim; Hiu Wing Cheung; Barbara A Weir; Gavin P Dunn; Rhine R Shen; William C Hahn
Journal:  Mol Cancer Res       Date:  2014-11-03       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.